Sorafenib inhibits hypoxia-induced HIF-1α protein synthesis, leading to decreased VEGF expression and lower tumor vascularization both in different HCC cell lines29,31 and HCC xenograft mice29. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.